With Migraine, as with many other diseases and conditions, there are fewer medications that have been approved by the FDA for children than there are for adults. Much of this is because we naturally want to protect children, so researchers are reluctant to conduct clinical trials involving children, at least until after a medication has been used by adults for a significant period of time.

In December, the FDA granted a supplemental new drug application for the triptan Maxalt for broader...